CyDex Pharmaceuticals, Inc. today announced that Theron (Ted) E. Odlaug, Ph.D. has been named as the company’s president and chief executive officer. Odlaug replaces John M. Siebert, Ph.D., who has retired as CyDex’s chief executive officer and has stepped down as chairman of the company’s board of directors. Siebert will remain a consultant to the company to aid in the transition. The board of directors appointed Odlaug to the board and has elected director James C. Gale as its new chairman. Odlaug joined CyDex as president and chief operating officer in May 2008. In his new role, he will be responsible for day-to-day operations and corporate strategy. “Ted’s extensive experience in the pharmaceutical and life sciences arenas and his in-depth knowledge of CyDex make him the ideal candidate to lead the company,” said Siebert....
[read full story]
Your Web Site
